Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Perrild

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Ugeskrift for Laeger|April 16, 2013
[Changes in thyroid disease in Denmark]Peter Laurberg, Stine Linding Andersen, Anne Krejbjerg Motavaf, et al.
The Journal of Clinical Endocrinology and Metabolism|December 15, 2018
Increased Incidence Rate of Hypothyroidism After Iodine Fortification in Denmark: A 20-Year Prospective Population-Based StudyMads Petersen, Nils Knudsen, Allan Carlé, et al.
Clinical Endocrinology|June 1, 2018
Thyrotoxicosis after iodine fortification. A 21-year Danish population-based studyMads Petersen, Nils Knudsen, Allan Carlé, et al.
The Journal of Clinical Endocrinology and Metabolism|September 11, 2012
Predictors of change in serum TSH after iodine fortification: an 11-year follow-up to the DanThyr studyLena Bjergved, Torben Jørgensen, Hans Perrild, et al.
Ugeskrift for Laeger|December 14, 2011
[Iodine fortification of salt and thyroid disease in Denmark]Peter Laurberg, Torben Jørgensen, Lars Ovesen, et al.
BMC Endocrine Disorders|June 26, 2012
A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): study rationale and designPeter Lommer Kristensen, Ulrik Pedersen-Bjergaard, Henning Beck-Nielsen, et al.
Diabetes Technology & Therapeutics|March 23, 2018
Effect of Insulin Analogs on Frequency of Non-Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose-The HypoAna TrialRikke Mette Agesen, Peter Lommer Kristensen, Henning Beck-Nielsen, et al.
Diabetes Research and Clinical Practice|December 25, 2016
The potential for improvement of outcomes by personalized insulin treatment of type 1 diabetes as assessed by analysis of single-patient data from a randomized controlled cross-over insulin trialUlrik Pedersen-Bjergaard, Peter L Kristensen, Henning Beck-Nielsen, et al.
Diabetes/Metabolism Research and Reviews|February 18, 2011
Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapyKim Henriksen, Inger Byrjalsen, Per Qvist, et al.
The Lancet. Diabetes & Endocrinology|May 6, 2014
Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trialUlrik Pedersen-Bjergaard, Peter Lommer Kristensen, Henning Beck-Nielsen, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Ugeskrift for Laeger|April 16, 2013
[Changes in thyroid disease in Denmark]Peter Laurberg, Stine Linding Andersen, Anne Krejbjerg Motavaf, et al.
The Journal of Clinical Endocrinology and Metabolism|December 15, 2018
Increased Incidence Rate of Hypothyroidism After Iodine Fortification in Denmark: A 20-Year Prospective Population-Based StudyMads Petersen, Nils Knudsen, Allan Carlé, et al.
Clinical Endocrinology|June 1, 2018
Thyrotoxicosis after iodine fortification. A 21-year Danish population-based studyMads Petersen, Nils Knudsen, Allan Carlé, et al.
The Journal of Clinical Endocrinology and Metabolism|September 11, 2012
Predictors of change in serum TSH after iodine fortification: an 11-year follow-up to the DanThyr studyLena Bjergved, Torben Jørgensen, Hans Perrild, et al.
Ugeskrift for Laeger|December 14, 2011
[Iodine fortification of salt and thyroid disease in Denmark]Peter Laurberg, Torben Jørgensen, Lars Ovesen, et al.
BMC Endocrine Disorders|June 26, 2012
A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): study rationale and designPeter Lommer Kristensen, Ulrik Pedersen-Bjergaard, Henning Beck-Nielsen, et al.
Diabetes Technology & Therapeutics|March 23, 2018
Effect of Insulin Analogs on Frequency of Non-Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose-The HypoAna TrialRikke Mette Agesen, Peter Lommer Kristensen, Henning Beck-Nielsen, et al.
Diabetes Research and Clinical Practice|December 25, 2016
The potential for improvement of outcomes by personalized insulin treatment of type 1 diabetes as assessed by analysis of single-patient data from a randomized controlled cross-over insulin trialUlrik Pedersen-Bjergaard, Peter L Kristensen, Henning Beck-Nielsen, et al.
Diabetes/Metabolism Research and Reviews|February 18, 2011
Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapyKim Henriksen, Inger Byrjalsen, Per Qvist, et al.
The Lancet. Diabetes & Endocrinology|May 6, 2014
Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trialUlrik Pedersen-Bjergaard, Peter Lommer Kristensen, Henning Beck-Nielsen, et al.
Pageof 10